Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Takeda Pharmaceutical Company Limited”

1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,022
Index total 30,257
Page 14 / 43

Quick answer

This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,022 results for “Takeda Pharmaceutical Company Limited” · 30,257 patents in full index Clear search

  1. US 10308635

    1-sulfonyl piperidine derivatives as modulators of prokineticin receptors

    Takeda Pharmaceutical Company Limited · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  2. US 10307414

    Pyridinyl and fused pyridinyl triazolone derivatives

    Takeda Pharmaceutical Company Limited · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  3. US 10301292

    Bicyclic compound

    Takeda Pharmaceutical Company Limited · Granted May 28, 2019 · Expires May 23, 2039

    granted

  4. US 10287305

    Substituted piperidine compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted May 14, 2019 · Expires May 9, 2039

    granted

  5. US 10287286

    Compounds

    Takeda Pharmaceutical Company Limited · Granted May 14, 2019 · Expires May 9, 2039

    granted

  6. US 10273225

    Pyrazines as modulators of GPR6

    Takeda Pharmaceutical Company Limited · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  7. US 10273245

    1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases

    Takeda Pharmaceutical Company Limited · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  8. US 10252974

    Cationic lipid

    Takeda Pharmaceutical Company Limited · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  9. US 10252997

    Monocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  10. US 10238605

    Dry coated tablet

    Takeda Pharmaceutical Company Limited · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  11. US 10231929

    Solid dispersion

    Takeda Pharmaceutical Company Limited · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  12. US 10226426

    Suspension containing nano-cocrystal and manufacturing method

    Takeda Pharmaceutical Company Limited · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted

  13. US 10214508

    Nitrogen-containing heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted

  14. US 10214498

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted

  15. US 10208046

    Nitrogen-containing heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  16. US 10208016

    1-sulfonyl piperidine derivatives as modulators of prokineticin receptors

    Takeda Pharmaceutical Company Limited · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  17. US 10202399

    Dihydroxy aromatic heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  18. US 10202376

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  19. US 10189785

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted

  20. US 10179783

    Tetrahydropyridopyrazines as modulators of GPR6

    Takeda Pharmaceutical Company Limited · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  21. US 10167273

    Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases

    Takeda Pharmaceutical Company Limited · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  22. US 10160745

    Piperidine and azepine derivatives as prokineticin receptor modulators

    Takeda Pharmaceutical Company Limited · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  23. US 10159677

    4-OXO-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139

    Takeda Pharmaceutical Company Limited · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  24. US 10144743

    1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases

    Takeda Pharmaceutical Company Limited · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.